Help shape the future of FierceBiotech IT

Do you have 3 minutes today to help my team shape the future of FierceBiotech IT?

We're hard at work every day to ensure FierceBiotech IT is the first place you turn for biopharma IT news and insight. We're proud you've joined 8,500 of your colleagues in choosing us as your go-to news source since our launch in early May. However, to be Fierce is to be constantly improving. That's why I'm asking today for your guidance via a quick 10 question reader survey.

Reader satisfaction drives the decisions we make at Fierce. As a result, our planning won't be complete without your unique perspective. Now is your chance to make an impact on the future of FierceBiotech IT.

Please click here to begin the survey.

Thanks for advising us. I'm grateful for your continued participation in the FierceBiotech IT community.

Arsalan Arif
Publisher, FierceBiotech IT
email l twitter

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.